Charles River Laboratories Selects Cyto Study Manager Software Solution
Leading Contract Research Organization Selects Cyto Study Manager to Optimize Genetic Toxicology Operations
CONSHOHOCKEN, PA – March 22, 2018 - -Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce that Charles River Laboratories (Charles River) has purchased the Cyto Study Manager genetic toxicology software solution.
Charles River selected Cyto Study Manager to streamline their genetic toxicology study workflows into one comprehensive web-based system that can be securely accessed from anywhere. Cyto Study Manager’s powerful features will enable Charles River to increase efficiencies to better serve their clients.
About Cyto Study Manager
Cyto Study Manager, originally developed by Perceptive Instruments and now part of the Instem solution portfolio, integrates genetox data acquisition, auditing, reporting and study management into a single system. This GLP compliant solution is revolutionizing genetox study workflows, and leading R&D organizations across the globe are deploying Cyto Study Manager to help them streamline genetic toxicology operations, reduce costs, increase efficiencies and improve regulatory compliance.
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600
Gary Mitchell (US HQ)